Robert E. Landry - 08 Dec 2023 Form 4 Insider Report for REGENERON PHARMACEUTICALS, INC. (REGN)

Role
EVP Finance CFO
Signature
/s/**Robert E. Landry
Issuer symbol
REGN
Transactions as of
08 Dec 2023
Net transactions value
-$3,573,573
Form type
4
Filing time
12 Dec 2023, 16:01:38 UTC
Previous filing
25 Aug 2023
Next filing
14 Dec 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction REGN Common Stock Tax liability $854,759 -1,013 -3.2% $843.79 30,686 08 Dec 2023 Direct
transaction REGN Common Stock Tax liability $564,696 -669 -2.2% $844.09 30,017 11 Dec 2023 Direct
transaction REGN Common Stock Tax liability $2,154,118 -2,552 -8.5% $844.09 27,465 11 Dec 2023 Direct
holding REGN Common Stock 270 08 Dec 2023 By 401(k) Plan
* An asterisk sign (*) next to the price indicates that the price is likely invalid.